Similar articles for PMID: 33517273

Year	Number of Results
1997	1
2001	2
2002	3
2006	4
2008	1
2009	5
2010	5
2011	6
2012	5
2013	7
2014	7
2015	4
2016	10
2017	7
2018	16
2019	23
2020	7
2021	4

1

A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.

Jiang C, Lee SH, Park JH, Lee JS, Park JW, Kim JR, Lee SH, Kim HS, Yoon S. Jiang C, et al. Anticancer Res. 2021 Feb;41(2):687-697. doi: 10.21873/anticanres.14820. Anticancer Res. 2021. PMID: 33517273

2

Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.

Kim JY, Park YJ, Lee BM, Yoon S. Kim JY, et al. Anticancer Res. 2019 Jul;39(7):3757-3765. doi: 10.21873/anticanres.13524. Anticancer Res. 2019. PMID: 31262902

3

P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.

Kim JY, Park Y, Lee BM, Kim HS, Yoon S. Kim JY, et al. Anticancer Res. 2018 Oct;38(10):5685-5692. doi: 10.21873/anticanres.12905. Anticancer Res. 2018. PMID: 30275188

4

Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.

Kim JY, Son JY, Lee BM, Kim HS, Yoon S. Kim JY, et al. Anticancer Res. 2018 Sep;38(9):5149-5157. doi: 10.21873/anticanres.12837. Anticancer Res. 2018. PMID: 30194162

5

Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.

Kim JY, Tae IH, Lee BM, Kim HS, Yoon S. Kim JY, et al. Anticancer Res. 2018 Sep;38(9):5101-5108. doi: 10.21873/anticanres.12830. Anticancer Res. 2018. PMID: 30194155

6

Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.

Kim JY, Kim KS, Kim IS, Yoon S. Kim JY, et al. Anticancer Res. 2019 Jul;39(7):3767-3775. doi: 10.21873/anticanres.13525. Anticancer Res. 2019. PMID: 31262903

7

Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.

Kim JY, Kim HS, Yoon S. Kim JY, et al. Anticancer Res. 2019 Jul;39(7):3785-3793. doi: 10.21873/anticanres.13527. Anticancer Res. 2019. PMID: 31262905

8

P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.

Cheon JH, Kim JY, Lee BM, Kim HS, Yoon S. Cheon JH, et al. Anticancer Res. 2017 Dec;37(12):6761-6769. doi: 10.21873/anticanres.12136. Anticancer Res. 2017. PMID: 29187454

9

The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.

Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S. Cheon JH, et al. Biochem Biophys Res Commun. 2017 Sep 2;490(4):1176-1182. doi: 10.1016/j.bbrc.2017.06.178. Epub 2017 Jun 29. Biochem Biophys Res Commun. 2017. PMID: 28669723

10

Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition.

Choi AR, Jee Jo M, Jung MJ, Sik Kim H, Yoon S. Choi AR, et al. Eur J Pharmacol. 2015 Oct 5;764:63-69. doi: 10.1016/j.ejphar.2015.06.046. Epub 2015 Jun 30. Eur J Pharmacol. 2015. PMID: 26134503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed